Drug profile · INN
dalteparin sodium
FRAGMIN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
dalteparin sodium (FRAGMIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN dalteparin sodium
Brand FRAGMIN
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is dalteparin sodium?
dalteparin sodium (FRAGMIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for dalteparin sodium?
FRAGMIN is a marketed brand name for dalteparin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dalteparin sodium?
dalteparin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.